Literature DB >> 6325133

Prepubertal ovarian function is finely regulated by direct adrenergic influences. Role of noradrenergic innervation.

L I Aguado, S R Ojeda.   

Abstract

In the rat, the main source of adrenergic fibers innervating nonvascular ovarian tissue is the superior ovarian nerve (SON). To determine the influence of the SON on prepubertal ovarian function and, hence, on the time of puberty, several experiments were conducted. Transection of the SON in early juvenile rats (day 24) led to more than 60% depletion in ovarian norepinephrine (NE) content, but affected neither the timing of vaginal opening nor that of first ovulation. SON section, however, produced a 2-fold increase in beta-adrenergic receptor density, with no change in affinity, suggesting that hypersensitivity by denervation had developed. Removal of all adrenergic influences from ovarian granulosa cells by culturing the isolated cells in vitro produced a striking increase in beta-adrenergic receptor number, which was maximal at 72 h. In spite of this elevated receptor content, the beta-adrenergic agonist Zinterol did not induce progesterone release unless the cells were previously exposed for 48 h to a physiological concentration of FSH. Both NE and epinephrine down-regulated the receptors in a dose-related manner, without affecting receptor affinity. To test the hypothesis that denervation of the ovary results in greater steroidal sensitivity to adrenergic stimulation, a model was constructed in which cells were simultaneously exposed to FSH and NE or epinephrine (innervated cells) or exposed only to FSH (denervated cells) for 48 h. The response to adrenergic stimulation was subsequently measured by incubating the cells with Zinterol for 24 h. Zinterol was highly effective in eliciting progesterone release from the denervated cells, but failed to do so in innervated cells. Additionally, the agonist increased cAMP in the former cells, but it was ineffective in the latter, indicating that prior exposure to catecholamines desensitized the adenyl cyclase enzyme coupled to beta-adrenergic receptor sites. The results suggest that during prepubertal maturation, noradrenergic fibers reaching the ovary via the SON may modify ovarian steridogenic sensitivity to catecholamines, by regulating the number of functional beta-adrenergic receptors in the gland. They also indicate that the apparent failure of SON denervation to alter the maturation of ovarian steroidogenesis and the time of puberty may be due to development of compensatory hypersensitivity after the denervation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325133     DOI: 10.1210/endo-114-5-1845

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

Review 1.  Role of cytokines in testicular function.

Authors:  D B Hales; T Diemer; K H Hales
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

Review 2.  Neuroendocrine influences on cancer progression.

Authors:  Guillermo N Armaiz-Pena; Steve W Cole; Susan K Lutgendorf; Anil K Sood
Journal:  Brain Behav Immun       Date:  2012-06-21       Impact factor: 7.217

3.  The participation of the cholinergic system in regulating progesterone secretion through the ovarian-adrenal crosstalk varies along the estrous cycle.

Authors:  Angélica Flores; Griselda Meléndez; María T Palafox; Jorge O Rodríguez; Ana I Barco; Roberto Chavira; Roberto Domínguez; M Esther Cruz
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

4.  Identification of functional alpha-adrenoceptor subtypes in the bovine female genital tract during different phases of the oestrous cycle.

Authors:  G Re; P Badino; R Odore; C Zizzadoro; P Ormas; C Girardi; C Belloli
Journal:  Vet Res Commun       Date:  2002-08       Impact factor: 2.459

5.  Role of the superior ovarian nerve in the regulation of follicular development and steroidogenesis in the morning of diestrus 1.

Authors:  Deyra A Ramírez Hernández; Elizabeth Vieyra Valdez; Gabriela Rosas Gavilán; Rosa Linares Culebro; Julieta A Espinoza Moreno; Andrea Chaparro Ortega; Roberto Domínguez Casalá; Leticia Morales-Ledesma
Journal:  J Assist Reprod Genet       Date:  2020-05-04       Impact factor: 3.412

6.  Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.

Authors:  Anil K Sood; Guillermo N Armaiz-Pena; Jyotsnabaran Halder; Alpa M Nick; Rebecca L Stone; Wei Hu; Amy R Carroll; Whitney A Spannuth; Michael T Deavers; Julie K Allen; Liz Y Han; Aparna A Kamat; Mian M K Shahzad; Bradley W McIntyre; Claudia M Diaz-Montero; Nicholas B Jennings; Yvonne G Lin; William M Merritt; Koen DeGeest; Pablo E Vivas-Mejia; Gabriel Lopez-Berestein; Michael D Schaller; Steven W Cole; Susan K Lutgendorf
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

7.  Asymmetric steroidogenic response by the ovaries to the vasoactive intestinal peptide.

Authors:  Gabriela Rosas; María Isabel Ramírez; Rosa Linares; Angélica Trujillo; Roberto Domínguez; Leticia Morales-Ledesma
Journal:  Endocrine       Date:  2014-10-21       Impact factor: 3.633

8.  Vasoactive intestinal peptide induces the synthesis of the cholesterol side-chain cleavage enzyme complex in cultured rat ovarian granulosa cells.

Authors:  W H Trzeciak; C E Ahmed; E R Simpson; S R Ojeda
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

9.  Oocytes are a source of catecholamines in the primate ovary: evidence for a cell-cell regulatory loop.

Authors:  A Mayerhofer; G D Smith; M Danilchik; J E Levine; D P Wolf; G A Dissen; S R Ojeda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Unilateral sectioning of the superior ovarian nerve of rats with polycystic ovarian syndrome restores ovulation in the innervated ovary.

Authors:  Leticia Morales-Ledesma; Rosa Linares; Gabriela Rosas; Carolina Morán; Roberto Chavira; Mario Cárdenas; Roberto Domínguez
Journal:  Reprod Biol Endocrinol       Date:  2010-08-19       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.